青青久久亚洲,国产日韩变态另类,国内精品夫妻久久视频

sdr***rui 2019-11-17 20:39 IP：臨沂

◆◆

急需液體敷料一類醫(yī)療器械備案全套申請(qǐng)資料及生產(chǎn)備案資料產(chǎn)品風(fēng)險(xiǎn)分析報(bào)告產(chǎn)品技術(shù)要求產(chǎn)品檢驗(yàn)報(bào)告臨床評(píng)價(jià)資料產(chǎn)品說(shuō)明書及標(biāo)簽樣稿與產(chǎn)品研制、生產(chǎn)有關(guān)的質(zhì)量管理體系文件生產(chǎn)制造信息符合性聲明 [更多]

項(xiàng)目合作>>產(chǎn)品注冊(cè)

懸賞：￥100.00

㖃項(xiàng)目合作>>產(chǎn)品注冊(cè)

懸賞

￥100.00

已托管

載入中...

1

Lik***291 2019-11-15 17:51 IP：重慶

◆◆

需要6篇文獻(xiàn)

1、targeting inhaled steroids 文獻(xiàn) 2、Minerva Dietol Gastroenterol. 1989 Jul-Sep;35(3):175-89. [A selective antimuscarinic agent: pirenzepine. Review of its pharmacologic and clinical properties]. [Article in Italian] Del Tacca M, Danesi R, Blandizzi C, Bernardini MC. 3、See 1 citation found by title matching your search: J Pharmacol. 1985;16 Suppl 2:145-69. [MI cholinergic receptors of gastric secretion: current status]. [Article in French]、 4、Carrigan PJ, Papp K, Schulz G, Venable T. Bioavailability of valproate from divalproex sodium tablets. Abbott Laboratories, North Chicago, IL (unpublished data). 5、MITOXANTRONE - MECHANISM OF ACTION, ANTITUMOR-ACTIVITY, PHARMACOKINETICS, EFFICACY IN THE TREATMENT OF SOLID TUMORS AND LYMPHOMAS, AND TOXICITY，文獻(xiàn) 6、American Journal of Kidney Diseases Volume 70, Issue 6, December 2017, Pages 737-751 KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) [更多]

特色服務(wù)>>信息服務(wù)

懸賞：￥60.00

㖃特色服務(wù)>>信息服務(wù)

懸賞

￥60.00

已托管

載入中...

4

zha***iyu 2019-11-12 10:06 IP：南京

◆◆

求購(gòu)“Phloroglucinoldihydrate”《EP9.2》的藥典信息一份.

需要間苯三酚EP最新版質(zhì)量標(biāo)準(zhǔn)，求助 [更多]

特色服務(wù)>>文獻(xiàn)檢索

懸賞：￥50.00

㖃特色服務(wù)>>文獻(xiàn)檢索

懸賞

￥50.00

已托管

載入中...

2

Lik***291 2019-11-08 09:46 IP：重慶

◆◆

需要5篇文獻(xiàn)

1、Nimesulide - a non-steroidal anti-inflammatory drug, a preferential cyclooxygenase-2 inhibitor 【出處】Vutreshni bolesti. 2000;32(1):33-6. 2、Bioequivalence study between two slow release batches ofindapamide SR 1.5 mg with different dissolution pro- files after repeated oral administration over 7 days in 12 healthy volunteers: a randomised double blind cross over study. Fulmer Hall, UK: Servier, 1993. Report No.: NP 910 3、Schiavi P, Jochemsen R, Hiley M, et al. Pharmacokinetics ofslow and immediate release formulations of indapamide after single oral administration under fasting conditions and after food, in healthy volunteers. Eur J Drug Metab Pharmacokinet 1996; Spe- cial Issue: 42 4、找一篇97年的政策法規(guī)文件，標(biāo)題：國(guó)家醫(yī)藥管理局國(guó)藥字（97）253號(hào)文件 5、Higuchi T, Murasaki M, Kamijima K. Clinical evaluation of duloxetine in the treatment of major depressive disorder. Jpn J Clin Psychopharmacol 2009;12:1613-1634 [更多]

特色服務(wù)>>信息服務(wù)

懸賞：￥50.00

㖃特色服務(wù)>>信息服務(wù)

懸賞

￥50.00

已托管

載入中...

hqplar 2019-11-06 14:51 IP：XX

◆◆

需要一份CRO臨床試驗(yàn)質(zhì)量管理體系（QMS）文件

本公司臨床部門需要一份比較完善且新的針對(duì)臨床試驗(yàn)全過(guò)程的質(zhì)量管理體系文件。質(zhì)量夠好可追加獎(jiǎng)勵(lì)。 [更多]

生產(chǎn)研發(fā)>>臨床試驗(yàn)